Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.

Hazenberg BP, Croockewit A, van der Holt B, Zweegman S, Bos GM, Delforge M, Raymakers RA, Sonneveld P, Vellenga E, Wijermans PW, von dem Borne PA, van Oers MH, de Weerdt O, Spoelstra FM, Lokhorst HM, Dutch-Belgian Cooperative Trial Group for Hematology Oncology

Open source

DOI: 10.3324/haematol.2014.119198
Published: 2015 May
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2014.119198,
  title = {Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.},
  author = {Hazenberg BP and Croockewit A and van der Holt B and Zweegman S and Bos GM and Delforge M and Raymakers RA and Sonneveld P and Vellenga E and Wijermans PW and von dem Borne PA and van Oers MH and de Weerdt O and Spoelstra FM and Lokhorst HM and Dutch-Belgian Cooperative Trial Group for Hematology Oncology},
  year = {2015},
  journal = {Haematologica},
  doi = {10.3324/haematol.2014.119198},
  url = {https://doi.org/10.3324/haematol.2014.119198}
}

RIS

TY  - JOUR
TI  - Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.
AU  - Hazenberg BP
AU  - Croockewit A
AU  - van der Holt B
AU  - Zweegman S
AU  - Bos GM
AU  - Delforge M
AU  - Raymakers RA
AU  - Sonneveld P
AU  - Vellenga E
AU  - Wijermans PW
AU  - von dem Borne PA
AU  - van Oers MH
AU  - de Weerdt O
AU  - Spoelstra FM
AU  - Lokhorst HM
AU  - Dutch-Belgian Cooperative Trial Group for Hematology Oncology
PY  - 2015
JO  - Haematologica
DO  - 10.3324/haematol.2014.119198
UR  - https://doi.org/10.3324/haematol.2014.119198
ER  -

APA

BP, H., A, C., B, V. D. H., S, Z., GM, B., M, D., RA, R., P, S., E, V., PW, W., PA, V. D. B., MH, V. O., O, D. W., FM, S., HM, L., & Oncology, D. C. T. G. F. H. (2015). Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.. Haematologica. https://doi.org/10.3324/haematol.2014.119198

Source records

pubmed · retrieved 2026-09-26T16:26:49.837Z